What is the recommended dosage and management of Fludrocortisone (a mineralocorticoid) for patients with primary adrenal insufficiency, such as Addison's disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fludrocortisone Dosage and Management in Primary Adrenal Insufficiency

Most patients with primary adrenal insufficiency should take 50-200 μg fludrocortisone as a single daily dose, with children and younger adults potentially requiring higher doses. 1

Standard Dosing Recommendations

  • Initial dosage: 0.1 mg (100 μg) fludrocortisone daily 2
  • Dosage range: 0.05-0.2 mg daily, or as specific as:
    • 0.1 mg daily (standard dose)
    • 0.1 mg three times weekly (lower end)
    • 0.2 mg daily (higher end) 2

Dosage Adjustment Factors

Clinical Parameters to Monitor

  • Blood pressure (standing and supine)
  • Serum electrolytes (sodium and potassium)
  • Plasma renin activity (PRA) - aim for upper normal range 3
  • Salt craving
  • Presence of peripheral edema
  • Overall sense of well-being

Dose Reduction Needed When:

  • Hypertension develops (reduce to 0.05 mg daily) 2
  • Essential hypertension develops (reduce dose but do not stop) 1

Dose Increase Needed When:

  • Hypotension persists
  • Hyperkalemia occurs
  • Hyponatremia occurs
  • Salt craving continues
  • Elevated plasma renin activity 4

Special Populations

Children and Young Adults

  • May require higher doses than adults 1
  • Dosing should be adjusted based on clinical response and laboratory parameters

Pregnancy

  • Dose adjustments often needed during pregnancy, particularly in the last trimester
  • Increased requirements due to anti-mineralocorticoid effects of progesterone 1, 3
  • Monitor blood pressure, electrolytes, and symptoms closely

Hot Weather/High Temperature

  • May need dose adjustments in high ambient temperatures to avoid sodium depletion 3

Administration Guidelines

  • Administer as a single daily dose, preferably in the morning 2
  • Always administer in conjunction with glucocorticoid replacement (typically hydrocortisone 15-25 mg daily in divided doses) 1, 5
  • Patients should be advised to consume salt and salty foods freely 1
  • Avoid licorice and grapefruit juice (can potentiate mineralocorticoid effects) 1

Monitoring Protocol

Regular Assessment

  • Annual review at minimum 1
  • Measure weight, blood pressure, and serum electrolytes
  • Consider plasma renin activity measurements to guide dosing 4, 3

Medication Interactions

Adjust fludrocortisone dosing when patients are on:

  • Diuretics
  • NSAIDs
  • Carbenoxolone
  • Drospirenone-containing contraceptives 1

Special Considerations

Surgery and Medical Procedures

  • Continue fludrocortisone during minor procedures
  • For major surgery, restart when hydrocortisone dose falls below 50 mg/day 1

Adrenal Crisis Management

  • Focus on hydrocortisone and fluid replacement during crisis
  • Resume fludrocortisone once stabilized on maintenance hydrocortisone 1

Long-term Follow-up

  • Some patients may require dose reduction over time (particularly after >60 months of treatment) 4
  • Regular monitoring remains essential even in stable patients

By following these guidelines for fludrocortisone dosing and monitoring, patients with primary adrenal insufficiency can achieve optimal mineralocorticoid replacement, reducing morbidity and mortality associated with this condition.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Mineralocorticoid substitution and monitoring in primary adrenal insufficiency.

Best practice & research. Clinical endocrinology & metabolism, 2015

Research

Replacement therapy for Addison's disease: recent developments.

Expert opinion on investigational drugs, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.